TD Securities (USA)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $6K | Buy |
18
+1
| +6% | +$333 | 0.05% | 172 |
|
|
2015
Q4 | $9K | Sell |
17
-27
| -61% | -$14.3K | 0.08% | 118 |
|
|
2015
Q3 | $20K | Sell |
44
-30,489
| -100% | -$13.9M | 0.18% | 122 |
|
|
2015
Q2 | $15.6M | Buy |
30,533
+4,031
| +15% | +$2.06M | 0.21% | 121 |
|
|
2015
Q1 | $12M | Sell |
26,502
-1,680
| -6% | -$758K | 0.18% | 137 |
|
|
2014
Q4 | $11.6M | Buy |
28,182
+2,375
| +9% | +$974K | 0.17% | 147 |
|
|
2014
Q3 | $9.3M | Sell |
25,807
-2,053
| -7% | -$740K | 0.15% | 165 |
|
|
2014
Q2 | $7.87M | Buy |
27,860
+2,017
| +8% | +$570K | 0.13% | 194 |
|
|
2014
Q1 | $7.76M | Sell |
25,843
-1,867
| -7% | -$561K | 0.14% | 184 |
|
|
2013
Q4 | $7.63M | Buy |
27,710
+1,000
| +4% | +$275K | 0.13% | 195 |
|
|
2013
Q3 | $8.36M | Buy |
26,710
+666
| +3% | +$208K | 0.16% | 148 |
|
|
2013
Q2 | $5.86M | Buy |
+26,044
| New | +$5.86M | 0.12% | 207 |
|